AI: Regulatory Framework for SaMD – Part Two
May 12, 2021
By Cameron Loper, Digital Health Leader, MPR Associates
The U.S. Food and Drug Administration (FDA) has proposed a regulatory framework around Artificial Intelligence/Machine Learning (AI/ML) for software as a medical device (SaMD). In the second part of a two-part series, past and current regulations are explored and explained.
Full story